Search

All eyes on the future symposium hailed a great success

Leading providers in the eye healthcare sector, Optegra Eye Health Care and ZEISS, have successfully hosted their annual CPD-accredited symposium, ‘All Eyes on the Future’, bringing together experts from across the ophthalmic sector. The symposium welcomed 90 attendees, including optometrists,...

The College and AOP welcome plans to introduce compulsory eyesight testing for drivers in road safety push

Government proposals for mandatory eyesight testing for drivers over the age of 70 follow active campaigning by The College of Optometrists and the Association of Optometrists on road safety. The College of Optometrists and the Association of Optometrists welcome the...

Eye scans detect signs of Parkinson’s disease up to seven years before diagnosis

A team led by Siegfried Wagner and Pearse Keane of Moorfields Eye Hospital and UCL Institute of Ophthalmology (and spanning UCL institutions) has identified markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation.

World-first platform for transparent, fair and equitable use of AI in healthcare

Revolutionary AI platform for detecting diabetic eye disease proven safe for NHS. Researchers have developed the world’s first real-world head-to-head testing platform to determine whether commercial artificial intelligence (AI) algorithms are fit for NHS use to detect disease in a...

Artists Unite: hear from artist Lindsey Whitelaw

An art exhibition examining sight loss opened as part of the Wandsworth Arts Fringe in London on 10 June. Artist Lindsey Whitelaw spoke to Eye News about her process, and the influence of visual impairment on her work.

Obituary: Sohan Singh Hayreh (1927 - 2022)

Sohan would have been 95 on 6 November this year, but due to complications of COVID-19, he passed away on 29 September.

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Inequities in access to education for blind and partially sighted children

Leading Scottish vision impairment organisations call on Scottish Government to endorse new framework for vision impairment education.

Effective treatment for rare sight-threatening infection

A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.